Cardiovascular diseases (CVDs), such as atherosclerosis, myocardial infarction (MI), arrhythmias, hypertension, heart failure (HF) and stroke, are the umbrella term for all heart and brain diseases associated with vascular lesions and are the number one killer of human health. However, despite the considerable investment in healthcare, the clinical outcomes of these diseases need to be further enhanced.
The pathogenesis of these diseases is complex and has not yet been fully elucidated. Currently, pharmacological treatment is the primary intervention for cardiovascular disease, including aspirin, clopidogrel, ticagrelor, nitrates, statins, beta-blockers, sacubitril valsartan, sodium/glucose cotransporter-2 inhibitors (SGLT2i), and recombinant human brain natriuretic peptide are widely used in patients with cardiovascular disease. Clinical treatments are also widely used for vascular stenosis and thrombotic diseases, such as percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), thrombus aspiration, thrombectomy for cerebral infarction and thrombolysis. In addition, radiofrequency ablation, cryoablation and left atrial appendage closure are used to treat cardiac arrhythmias such as atrial fibrillation. Although significant advances have been made in diagnosing and treating cardiovascular disease over the past 20 years, results have been limited, and morbidity and mortality rates remain high.
In this research topic, we aim to highlight novel potential therapeutic targets for treating cardiovascular diseases. Furthermore, we would like to discuss the underlying mechanisms associated with these diseases, including clinical and basic research. Therefore, the search for new and effective strategies, including digital medicine, new materials, new interventional therapies, antithrombotic approaches, and strategies for managing complications, is essential in the fight against cardiovascular disease. This research topic takes an integrated view of various emerging strategies for cardiovascular disease. It will track new pathways for novel research and provide new concepts for diagnosing, treating, and preventing cardiovascular disease.
We welcome Original Research Articles, Reviews, and Mini-Reviews submitted for Frontiers in Physiology.
Cardiovascular diseases (CVDs), such as atherosclerosis, myocardial infarction (MI), arrhythmias, hypertension, heart failure (HF) and stroke, are the umbrella term for all heart and brain diseases associated with vascular lesions and are the number one killer of human health. However, despite the considerable investment in healthcare, the clinical outcomes of these diseases need to be further enhanced.
The pathogenesis of these diseases is complex and has not yet been fully elucidated. Currently, pharmacological treatment is the primary intervention for cardiovascular disease, including aspirin, clopidogrel, ticagrelor, nitrates, statins, beta-blockers, sacubitril valsartan, sodium/glucose cotransporter-2 inhibitors (SGLT2i), and recombinant human brain natriuretic peptide are widely used in patients with cardiovascular disease. Clinical treatments are also widely used for vascular stenosis and thrombotic diseases, such as percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), thrombus aspiration, thrombectomy for cerebral infarction and thrombolysis. In addition, radiofrequency ablation, cryoablation and left atrial appendage closure are used to treat cardiac arrhythmias such as atrial fibrillation. Although significant advances have been made in diagnosing and treating cardiovascular disease over the past 20 years, results have been limited, and morbidity and mortality rates remain high.
In this research topic, we aim to highlight novel potential therapeutic targets for treating cardiovascular diseases. Furthermore, we would like to discuss the underlying mechanisms associated with these diseases, including clinical and basic research. Therefore, the search for new and effective strategies, including digital medicine, new materials, new interventional therapies, antithrombotic approaches, and strategies for managing complications, is essential in the fight against cardiovascular disease. This research topic takes an integrated view of various emerging strategies for cardiovascular disease. It will track new pathways for novel research and provide new concepts for diagnosing, treating, and preventing cardiovascular disease.
We welcome Original Research Articles, Reviews, and Mini-Reviews submitted for Frontiers in Physiology.
